XML 38 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY: (Tables)
 6 Months Ended
Sep. 30, 2014
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:  
Schedule of reconciliation of the numerator and denominator of basic and diluted earnings per share

A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
September 30

 

For the six months ended
September 30

 

 

 

2014

 

2013

 

2014

 

2013

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Net earnings (loss) from continuing operations

 

$
(1,496

)

$
9,438

 

$
(7,568

)

$
21,941

 

Net earnings (loss) from discontinued operations

 
(48

)
426

 
(1,580

)
1,018

 

Net earnings (loss)

 

$
(1,544

)

$
9,864

 

$
(9,148

)

$
22,959

 

Net earnings (loss) attributable to noncontrolling interest

 

—

 
25

 

—

 
(60

)

Net earnings (loss) attributable to Acxiom

 

$
(1,544

)

$
9,839

 

$
(9,148

)

$
23,019

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 
77,123

 
73,778

 
76,978

 
73,728

 

Basic earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$
(0.02

)

$
0.13

 

$
(0.10

)

$
0.30

 

Discontinued operations

 

$

—

 

$
0.01

 

$
(0.02

)

$
0.01

 

Net earnings (loss)

 

$
(0.02

)

$
0.13

 

$
(0.12

)

$
0.31

 

Net earnings (loss) attributable to noncontrolling interest

 

$

—

 

$

—

 

$

—

 

$

—

 

Net earnings (loss) attributable to Acxiom

 

$
(0.02

)

$
0.13

 

$
(0.12

)

$
0.31

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 
77,123

 
73,778

 
76,978

 
73,728

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

—

 
2,258

 

—

 
2,036

 

Diluted weighted-average shares outstanding

 
77,123

 
76,036

 
76,978

 
75,764

 

Diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Continuing operations

 

$
(0.02

)

$
0.12

 

$
(0.10

)

$
0.29

 

Discontinued operations

 

$

—

 

$
0.01

 

$
(0.02

)

$
0.01

 

Net earnings (loss)

 

$
(0.02

)

$
0.13

 

$
(0.12

)

$
0.30

 

Net earnings (loss) attributable to noncontrolling interest

 

$

—

 

$

—

 

$

—

 

$

—

 

Net earnings (loss) attributable to Acxiom

 

$
(0.02

)

$
0.13

 

$
(0.12

)

$
0.30

 

 

Schedule of antidilutive options, warrants and restricted stock units excluded from computation of earnings per share

Options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings (loss) per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
September 30

 

For the six months ended
September 30

 

 

 

2014

 

2013

 

2014

 

2013

 

Number of shares outstanding under options, warrants and restricted stock units

 

3,446

 

2,224

 

1,813

 

3,390

 

Range of exercise prices for options and warrants

 

$19.02-$62.06

 

$21.46-$62.06

 

$21.17-$62.06

 

$21.46-$62.06

 

 

Schedule of accumulated balances for each component of other comprehensive income

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

 

 

 

September 30,
2014

 

March 31,
2014

 

Foreign currency translation

 

$
11,793

 

$
13,686

 

Unrealized gain/(loss) on interest rate swap

 
63

 
(24

)

 

 

$
11,856

 

$
13,662